McGill receives ACP Samuel Eichold II Memorial Award for Contributions in Diabetes 

On April 27, Janet B. McGill, MD received the 2023 Samuel Eichold II Memorial Award for Contributions in Diabetes from the American College of Physicians during their annual Convocation ceremony in San Diego, California.  The award recognizes Dr. McGill’s research contributions, which have significantly improved the quality of care and clinical management of diabetes. Widely […]

McGill publishes evaluation of the MiniMed 670G HCL in a randomized controlled trial 

On January 1, Janet B. McGill, MD, MA, FACP, and collaborators had their work titled “Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial” published in “Diabetes Technology and Therapeutics.”  The focus was “to evaluate safety and effectiveness of MiniMed™ 670G hybrid closed loop (HCL) in comparison […]

McGill, Salam and McKee get first patient for clinical trial testing Biosense device for those with Type 1 Diabetes 

Washington University School of Medicine recently received a two-year grant of $360,000 from JDRF to fund research testing the efficacy of the Biosense handheld breath ketone monitor in persons with type 1 diabetes during care with insulin and with the addition of a sodium glucose transporter inhibitor drug.  Biosense is a non-invasive option to capillary […]

McGill receives national Outstanding Physician Clinician in Diabetes Award

On March 14, the American Diabetes Association announced the recipients of the 2022 National Scientific and Health Care Achievement Awards. Janet B. McGill, MD, MA, FACP was named as the recipient of the 2022 Outstanding Physician Clinician in Diabetes Award.   The award recognizes Dr. McGill’s meritorious contributions to diabetes clinical practice for over 30 years. […]